Abstract P5-02-44: Efficacy analysis of CDK4/6 inhibitors in combination with endocrine therapy treatment in HR+/HER2- breast cancer according to PAM50 intrinsic subtype: primary results of SOLTI-1801_CDK-PREDICT study

Pablo Tolosa, Eva Ciruelos, Cristina Hernándo et al.|Cancer Research|2023

Cited by 0